Omnaris Launch Delayed While Altana Sniffs Out Marketing Partner

Altana will need to secure a marketing agreement with an outside partner before introducing its newly approved allergic rhinitis treatment Omnaris (ciclesonide nasal spray), the company said

More from Archive

More from Pink Sheet